Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques

Overview of attention for article published in Frontiers in immunology, April 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 34,143 followers.

Check out the recent Front Immunol paper with @theNCI postdoc Dr. Sarkis Sarkis in @NCIResearchCtr https://t.co/TCRACBwiOx on SIV V2 focused antibodies in macaques. Congrats! #NCIFuture #CancerTraining https://t.co/fn5nBCcQxN https://t.co/ocfQ7EL1NX

06 Jun 2023

Reply Repost Favourite

Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques https://t.co/x03v39tyll

08 May 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251…

22 Apr 2023

Reply Repost Favourite

New Research: Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques: Introduction An efficacious HIV vaccine will need to elicit a complex package of innate,… https://t.co/HEs4QM

22 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.